Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
30 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
120 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
150 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
120 minute plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
90 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
60 minute plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
150 minute plasma cortisol measurement (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
90 minute plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
30 minute plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
180 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
240 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
180 minute plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
240 minute plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
210 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
210 minute plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
60 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
Urine cortisol/creatinine ratio (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
Urine cortisol level (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Cortisol midday level (procedure) |
Component |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Urinary cortisol analysis (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
Intravenous hydrocortisone therapy |
Direct substance |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Intravenous hydrocortisone therapy |
Direct substance |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Quantitative measurement of mass concentration of hydrocortisone in serum or plasma specimen obtained at a specified time (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Quantitative measurement of mass concentration of hydrocortisone in p.m. serum or plasma specimen (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Quantitative measurement of mass concentration of hydrocortisone in baseline serum or plasma specimen after adrenocorticotropin challenge (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Quantitative measurement of mass concentration of hydrocortisone in saliva specimen (procedure) |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Topical hydrocortisone allergy |
Causative agent (attribute) |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Allergy to hydrocortisone (finding) |
Causative agent (attribute) |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Topical compound hydrocortisone preparation allergy |
Causative agent (attribute) |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone aceponate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing ciprofloxacin and hydrocortisone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Hydrocortisone 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone cypionate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone sodium succinate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone valerate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone butyrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone probutate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone aceponate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone sodium phosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone 1% + Pramocaine 1% conventional release rectal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone 25 milligram/1 each conventional release rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 25 milligram/1 each conventional release rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing colistin and hydrocortisone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
Hydrocortisone- and oxytetracycline-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Product containing hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 5 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 5 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 5 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 5 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocortisone (as hydrocortisone sodium phosphate) 500 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone (as hydrocortisone sodium phosphate) 100 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
Product containing hydrocortisone and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
Ciprofloxacin- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Product containing clioquinol and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Product containing hydrocortisone and miconazole in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |